We are live on ! Find out more
MAA

Mraz Amerine & Associates Portfolio holdings

AUM $697M
1-Year Est. Return 19.37%
This Fund
S&P 500
This Quarter Est. Return
+5.38%
1 Year Est. Return
+19.37%
3 Year Est. Return
+69.82%
5 Year Est. Return
+110.04%
10 Year Est. Return
+414.75%
AUM
$208M
AUM Growth
+$11.3M
Cap. Flow
+$1.78M
Cap. Flow %
0.85%
Top 10 Hldgs %
52.81%
Holding
137
New
10
Increased
32
Reduced
27
Closed
6

Top Buys

Rank Stock Value
1
MKL icon
Markel Group
MKL
+$835K
2
WRB icon
W.R. Berkley
WRB
+$825K
3
WTM icon
White Mountains Insurance
WTM
+$620K
4
AXLL
AXIALL CORP COM STK (DE)
AXLL
+$518K
5
SJT
San Juan Basin Royalty Trust
SJT
+$400K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.14M
2
ABBV icon
AbbVie
ABBV
+$988K
3
AON icon
Aon
AON
+$656K
4
OFG icon
OFG Bancorp
OFG
+$567K
5
BIIB icon
Biogen
BIIB
+$232K

Sector Composition

Rank Sector Weight
1 Financials 54.26%
2 Energy 16.72%
3 Communication Services 5.41%
4 Technology 3.92%
5 Healthcare 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LBTYA icon
76
Liberty Global Class A
LBTYA
$3.68B
$391K 0.19%
11,960
-17
-0.1% -$549
VIG icon
77
Vanguard Dividend Appreciation ETF
VIG
$114B
$379K 0.18%
5,450
– –
EQT icon
78
EQT Corp
EQT
$32.3B
$378K 0.18%
7,833
-551
-7% -$25.6K
PXD
79
DELISTED
Pioneer Natural Resource Co.
PXD
$378K 0.18%
+2,000
New +$340K
INTC icon
80
Intel
INTC
$503B
$370K 0.18%
16,121
+944
+6% +$21.7K
NRG icon
81
NRG Energy
NRG
$25B
$369K 0.18%
13,491
+1
+0% +$27
IBM icon
82
IBM
IBM
$220B
$367K 0.18%
2,071
+209
+11% +$38K
MDT icon
83
Medtronic
MDT
$110B
$366K 0.18%
6,878
– –
GD icon
84
General Dynamics
GD
$105B
$359K 0.17%
4,100
– –
SO icon
85
Southern Company
SO
$107B
$349K 0.17%
8,466
– –
BWP
86
DELISTED
Boardwalk Pipeline Partners
BWP
$349K 0.17%
11,501
– –
AMAT icon
87
Applied Materials
AMAT
$419B
$347K 0.17%
19,800
– –
EMR icon
88
Emerson Electric
EMR
$87.5B
$340K 0.16%
5,250
– –
COP icon
89
ConocoPhillips
COP
$140B
$336K 0.16%
4,832
– –
PFE icon
90
Pfizer
PFE
$149B
$328K 0.16%
12,021
– –
DMND
91
DELISTED
DIAMOND FOODS, INC.
DMND
$324K 0.16%
13,747
– –
STRZA
92
DELISTED
Starz - Series A
STRZA
$312K 0.15%
11,085
– –
TSI
93
TCW Strategic Income Fund
TSI
$212M
$309K 0.15%
57,418
– –
HGT
94
DELISTED
Hugoton Royalty Trust
HGT
$304K 0.15%
40,740
– –
XOM icon
95
ExxonMobil
XOM
$642B
$302K 0.15%
3,510
+1
+0% +$90
DD icon
96
DuPont de Nemours
DD
$19.5B
$299K 0.14%
3,070
– –
GLNG icon
97
Golar LNG
GLNG
$5.19B
$294K 0.14%
7,800
+900
+13% +$33K
GE icon
98
GE Aerospace
GE
$389B
$286K 0.14%
2,499
– –
LBTYK icon
99
Liberty Global Class C
LBTYK
$3.58B
$284K 0.14%
9,300
-18
-0.2% -$541
BAC icon
100
Bank of America
BAC
$441B
$283K 0.14%
20,531
+300
+1% +$4.28K
2 3
4
5 6

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Mraz Amerine & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Mraz Amerine & Associates held 137 positions worth $208M, up 5.7% from $197M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Mraz Amerine & Associates's Q3 2013 filing shows 10 new, 32 increased, 27 reduced and 6 closed positions. Its largest new stake was AXIALL CORP COM STK (DE): 12,400 shares worth $469K. The largest sale was GSK, an estimated $1.14M.

By sector, the portfolio is most concentrated in Financials at 54% of assets, down from 55% a quarter earlier, followed by Energy and Communication Services.

  • Mraz Amerine & Associates's largest Q3 2013 buy was AXIALL CORP COM STK (DE): 12,400 shares worth $469K.
  • Mraz Amerine & Associates added most to Markel Group in Q3 2013, an estimated $835K increase.
  • Mraz Amerine & Associates's biggest Q3 2013 reduction was AbbVie, cutting an estimated $988K.
  • Mraz Amerine & Associates fully exited GSK in Q3 2013, selling an estimated $1.14M.
  • Mraz Amerine & Associates's ten largest holdings make up 53% of its $208M portfolio in Q3 2013.
  • Mraz Amerine & Associates opened 10 new positions and closed 6 in Q3 2013.
  • Mraz Amerine & Associates's portfolio value rose 5.7% quarter-over-quarter to $208M.

Based on Mraz Amerine & Associates's 13F filing for Q3 2013, filed 18 Oct 2013.